Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,007
Closed -$5.43K 954
2025
Q2
$5.43K Hold
12,007
﹤0.01% 689
2025
Q1
$4.89K Sell
12,007
-906
-7% -$581 ﹤0.01% 643
2024
Q4
$8.55K Sell
12,913
-4,959
-28% -$3.44K ﹤0.01% 568
2024
Q3
$15.2K Sell
17,872
-11,304
-39% -$8.64K ﹤0.01% 516
2024
Q2
$19.5K Sell
29,176
-4,038
-12% -$3.35K ﹤0.01% 494
2024
Q1
$43.2K Sell
33,214
-57
-0.2% -$60 0.01% 460
2023
Q4
$19.1K Hold
33,271
﹤0.01% 453
2023
Q3
$25.1K Hold
33,271
﹤0.01% 430
2023
Q2
$24.3K Hold
33,271
﹤0.01% 427
2023
Q1
$25.2K Sell
33,271
-415
-1% -$385 ﹤0.01% 441
2022
Q4
$32.4K Buy
33,686
+3,195
+10% +$4.51K ﹤0.01% 441
2022
Q3
$66K Sell
30,491
-4,662
-13% -$16.1K 0.01% 431
2022
Q2
$123K Sell
35,153
-179
-0.5% -$669 0.02% 428
2022
Q1
$178K Buy
35,332
+5,255
+17% +$26.6K 0.02% 458
2021
Q4
$189K Sell
30,077
-1,546
-5% -$10.6K 0.03% 457
2021
Q3
$251K Hold
31,623
0.04% 394
2021
Q2
$237K Buy
31,623
+4,004
+14% +$28K 0.04% 395
2021
Q1
$167K Buy
+27,619
New +$212K 0.03% 423

Other funds holding VXRT

Ausdal Financial Partners's VXRT Position: Q3 2025 in Review

Ausdal Financial Partners sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 12,007 shares — an estimated $5.43K sold.

Ausdal Financial Partners first reported a position in VXRT in Q1 2021 and held it in 18 quarters. The position peaked at $251K in Q3 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Ausdal Financial Partners reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Ausdal Financial Partners sold 12,007 Vaxart shares in Q3 2025, an estimated $5.43K.
  • Ausdal Financial Partners first reported a position in Vaxart in Q1 2021 and held it in 18 quarters.
  • Ausdal Financial Partners's Vaxart position peaked at $251K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Ausdal Financial Partners's 13F filing for Q3 2025, filed 14 Nov 2025.